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Abstract
Background: Mixed epithelial and stromal tumour (MEST) represents a recently described benign composite
neoplasm of the kidney, which predominantly affects perimenopausal females. Most tumours are benign, although
rare malignant cases have been observed.
Case report: A 47-year-old postmenopausal female presented to the urologist with flank pain. A CT scan of the
abdomen showed a 30-mm-in-diameter uniform mass adjacent to the pelvis of the left kidney. Surgical exploration
showed a tumour arising from the lower anterior hilus of the left kidney. The tumour could be excised by
preserving the kidney. By intraoperative frozen section the tumour showed characteristic features of MEST with
epithelial-covered cysts embedded in an “ovarian-like” stroma. Additional immunohistochemistry investigations
showed expression for hormone receptors by the stromal component of the tumour.
Discussion: MEST typically presents in perimenopausal women as a primarily cystic mass. Commonly, the tumour
arises from the renal parenchyma or pelvis. The tumour is composed of an admixture of cystic and sometimes
more solid areas. The stromal cells typically demonstrate an ovarian-type stroma showing expression for the
estrogen and progesterone receptors.
Conclusion: MEST represents a distinctive benign tumour entity of the kidney, which affects perimenopausal
woman. The tumour should be distinguished from other cystic renal neoplasms. By imaging studies it is difficult to
distinguish between a benign or malignant nature of the tumour. Thus, intraoperative frozen section is necessary
for conservative surgery, since the overall prognosis is favourable and renal function can be preserved in most
cases.
Background
The mixed epithelial and stromal tumour (MEST) of the
kidney represents a recently described benign tumour,
which has to be distinguished from other renal neo-
plasms. The term MEST was first introduced by Michal
and Syucek in 1998[1]. Morphologically, the tumour is
characterized by a biphasic proliferation of stromal cells
with an epithelial component showing cystic dilatation.
The vast majority of cases show a benign course without
tumour recurrence [2-4].
We report the unusual case of a MEST arising from
the left kidney as a cystic tumour in an exophytic
fashion. Since the diagnosis was secured by intraopera-
tive frozen section, tumour excision without nephrect-
omy could be performed as treatment of choice.
Case presentation
A 47-year-old postmenopausal female patient presented
to us with increasing left-sided flank pain. Physical
examination was unremarkable. Aside from a well-med-
icinally treated hypertension no accompanying disease
was present. Her routine blood investigations were nor-
mal. Urine cytology revealed suspicions of atypical
urothelial cell elements. Retrograde ureterography
showed an obstruction of the proximal left ureter due
to a tumour projecting to the lower-left renal pelvis
(Figure 1a). A contrast-enhanced computerized
tomographic scan of the abdomen and pelvis showed a
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the hilar side of the lower pole of the left kidney with
minimal contrast enhancement (Figure 1b). Because of
renal obstruction a stent was inserted into the left
ureter. There was no evidence of lymph node or distant
metastases.
On surgical exploration there was a well-circum-
scribed tumour mass arising from the lower anterior
pole of the left kidney attached with a narrow pedicle to
the papilla of the lower chalice group (Figure 2). The
tumour could be excised completely. Frozen section
revealed a solid and cystic tumour of probably benign
nature, most probably MEST. After insertion of a dou-
ble-J stent into the left ureter the renal pelvis was
closed. No post-operative complications were observed.
Results
Pathologic findings
Gross examination showed a 2.5 × 2 × 1.5-cm-in-
diameter, well-encapsulatedp a r t l yc y s t i ct u m o u rw i t ha
2-cm-long narrow pedicle. Histologically, the tumour
was composed of cysts embedded in a collagenous
stroma containing bundles of spindle cell proliferations
with variable cellularity. The cysts varied significantly in
diameter and were covered by a flat or cuboidal epithe-
lium with areas of clear cell differentiation and hobnail
appearance. The thickness of the cyst septi ranged from
one to 6 mm microscopically. The relative proportion of
the stromal component to the entire tumor (stroma to
cyst ratio) was about 55%. No dysplasia, increased mito-
tic activity or tumour necrosis as signs for malignant
transformation were observed. A distinctive feature was
focal condensation of stromal cell adjacent to the cysts
(Figure 3a and 3b). By immunohistochemical investiga-
tions, the epithelial cells demonstrated expression for
pan-cytokeratin and cytokeratin-7 (Figure 3c), whereas
the stromal cells demonstrated co-expression for
mesenchyme markers such asv i m e n t i n ,d e s m i n ,a n d
smooth-muscle (sm) actin (Figure 3d). Focally, expres-
sion for CD10 and alpha-inhibin by stromal cells could
be observed. Constantly, the latter areas demonstrated
moderate to strong nuclear expression for the estrogen-
and progesterone-receptors (Figures 3e and 3f), thus
resembling a so-called “ovarian-like” s t r o m a .F o c a l l y ,a
Figure 1 Retrograde ureterography demonstrated a sharply circumscribed tumour mass (black arrow) leading to obstruction of the
proximal left ureter (a). Contrast enhanced CT-Scan showed a homogenous mass located adjacent to the lower hilus of the left kidney (white
arrow) without significant contrast enhancement (b).
Figure 2 Surgical specimen.U p o nr e m o v a lt h em a s sr e v e a l e da
well defined tumour originating with a narrow pedicle from the
papilla of the lower chalice group.
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Discussion
Mixed epithelial and stromal tumour (MEST) represents a
recently described tumour entity of the kidney of
unknown etiology [2,5,6]. In the past other synonyms,
such as cystic harmatoma of the renal pelvis, adult
mesoblastic nephroma, and cystic nephroma with “cellu-
lar” or “ovarian-type” stroma were applied [2]. About 50
cases have been reported in the literature so far [2,3,5,7,8].
Typically, the tumour presents in perimenopausal woman
as a combined solid and cystic tumour mass. The mean
age of clinical presentation is about 45 years.
The patients usually present to the urologist with non-
specific symptoms, such as flank pain, hematuria, or
Figure 3 Low magnification shows a tumour composed of large cysts as well as microcysts, and tubules embedded in a fibrous
stroma (A, H&E, ×40). Focally, an “ovarian-like” stroma was observed (B, H&E, ×100). The epithelial component demonstrated expression for
cytokeratin-7 (C, ×100), whereas the “ovarian-like” stroma showed coexpression for smooth-muscle actin (D, ×100) as well as for estrogen (E, ×100)
and progesterone receptors (F, ×100).
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t i o n s .T h em e a nt u m o u rs i z ea tp r i m a r yd i a g n o s i si s
about 6 cm in diameter [2,5,6]. Different hypothesis
have been proposed for its origin. The most popular
postulation is based on a disturbed hormonal environ-
ment, which is typically observed in perimenopausal
women or which may be caused by therapeutically
applied female hormones. Thus, hormonal imbalance
might induce the proliferation of a misplaced immature
or fetal mesenchyme, which harbours the capacity for a
dual, epithelial and mesenchymal differentiation [2,5,6].
This theory is driven by the observation of the expres-
sion for the estrogen and progesterone receptor within
the stromal cells by nearly all cases of MEST [2,5,6]. In
addition, the latter hypothesis is supported by a study
showing that most of the affected women had a long
history of treatment with estrogens. However, the only
male patient reported so far had a history of diethylstil-
bestrol therapy for 7 years, applied because of treatment
for prostatic cancer.
Nearly all cases described so far demonstrated a
benign course without tumour recurrence. However,
four cases of aggressive MEST have been described in
t h el i t e r a t u r es of a r[ 9 - 1 2 ] . Three patients with MEST
with local recurrence of tumour showing a fatal course
have been described. In two patients, the recurrent
tumour was composed exclusively of malignant trans-
formed stroma [10]. One case displayed malignant
transformation of MEST to a sarcomatoid carcinoma
with heterologeous differentiation [9].
The differential diagnoses include renal tumours,
which can show at least a partly cystic morphology,
such as partially cystic differentiated nephroblastoma,
multilocular cystic renal carcinoma, angiomyolipoma
with epithelial cysts or in rare cases synovial sarcoma
[2,5,6].
MEST demonstrate morphological overlap to cystic
nephroma, with which it can be confused [13,14]. Both
entities show some remarkable similarities including sex
predilection, age distribution, and morphological attri-
butes of the epithelial and stromal components as well
as immunohistochemical profile [15]. Albeit there are
some variations in the individual categories with a
higher prevalence of stromal-to-epithelial ratio, promi-
nent ovarian stroma, smaller cysts more common in
MEST; in contrast larger cysts with only thin septa
(with septa being smaller than 5 mm) and in addition a
lower stromal-to-epithelial ratio are typically observed in
cystic nephroma [2]. However, the presence of ovarian-
like stroma and müllerian-related immunohistochemical
markers raise the possibility that these tumours might
originate from müllerian remnants displaced during
embryogenesis [2,5,16].
Since some tumours have gross and microscopic fea-
tures intermediate between cystic nephroma and MEST,
it is considered that both tumours might represent dif-
ferent morphological variants of the same tumour entity
[2,5-7,14,17,18]. Therefore, Turbiner et al. (2007) pro-
posed to summarize both tumours under the unifying
term “renal epithelial and stromal tumour” (REST)[2].
However, this proposal is primarily based on the obser-
vation of an ovarian-like stroma in both tumour entities,
but since this kind of stroma is also observed in
obstructed kidneys, even without neoplasia some
authors consider the stromal differentiation as a form of
reactive metaplasia [17,19]. In a recent study, Zhou et
al. [20] investigated the relationship of cystic nephroma
and MEST compared to other renal tumours and nor-
mal kidney by using mRNA based gene expression pro-
filing and additional extensive histologic analyses.
Unsupervised clustering of mRNA expression profiles
demonstrated that cystic nephroma and MEST had very
similar expression profiles, which were distinct from
other renal neoplasms. Thus, the data of Zhou et al.
provide additional convincing molecular evidence that
cystic nephroma and MEST represent indeed one dis-
ease entity. However, since there are no specific molecu-
lar markers for the differentiation of MEST from cystic
nephroma and there are no further clues to the origin
of both tumour entities, a definitive classification
remains outstanding [17].
Conclusion
Mixed epithelial and stromal tumour represents a dis-
tinctive benign tumour of the kidney that should be dis-
tinguished from other cystic renal neoplasms. Prognosis
of this tumour is favourable in nearly all cases published
so far. Only rare cases of malignant transformation have
been published. In summary, MEST represents a benign
mostly cystic tumour of the kidney, which is predomi-
nately observed in middle aged, perimenopausal women.
K n o w l e d g eo ft h i sc e r t a i nb u tr a r et u m o u re n t i t yi s
important, since in most cases conservative surgery with
preservation of kidney function is the therapy of choice.
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